Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry)
Women typically present with coronary artery disease later than men with more unfavorable clinical and anatomic characteristics. It is unknown whether differences exist in women undergoing treatment for unprotected left main coronary artery (ULMCA) disease. Our aim was to evaluate long-term clinical...
Gespeichert in:
Veröffentlicht in: | The American journal of cardiology 2014-04, Vol.113 (8), p.1348-1355 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1355 |
---|---|
container_issue | 8 |
container_start_page | 1348 |
container_title | The American journal of cardiology |
container_volume | 113 |
creator | Buchanan, Gill Louise, MBChB Chieffo, Alaide, MD Meliga, Emanuele, MD Mehran, Roxana, MD Park, Seung-Jung, MD Onuma, Yoshinobu, MD Capranzano, Piera, MD Valgimigli, Marco, MD Narbute, Inga, MD Makkar, Raj R., MD Palacios, Igor F., MD Kim, Young-Hak, MD Buszman, Piotr P., MD Chakravarty, Tarun, MD Sheiban, Imad, MD Naber, Christoph, MD Margey, Ronan, MD Agnihotri, Arvind, MD Marra, Sebastiano, MD Capodanno, Davide, MD, PhD Allgar, Victoria, BSc (Hons), PhD Leon, Martin B., MD Moses, Jeffrey W., MD Fajadet, Jean, MD Lefevre, Thierry, MD Morice, Marie-Claude, MD Erglis, Andrejs, MD Tamburino, Corrado, MD, PhD Alfieri, Ottavio, MD Serruys, Patrick W., MD Colombo, Antonio, MD |
description | Women typically present with coronary artery disease later than men with more unfavorable clinical and anatomic characteristics. It is unknown whether differences exist in women undergoing treatment for unprotected left main coronary artery (ULMCA) disease. Our aim was to evaluate long-term clinical outcomes in women treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary artery bypass grafting (CABG). All consecutive women from the Drug-Eluting stent for LefT main coronary Artery disease registry with ULMCA disease were analyzed. A propensity matching was performed to adjust for baseline differences. In total, 817 women were included: 489 (59.8%) underwent treatment with PCI with drug-eluting stents versus 328 (40.2%) with CABG. Propensity score matching identified 175 matched pairs, and at long-term follow-up there were no differences in all-cause (odds ratio [OR] 0.722, 95% confidence interval [CI] 0.357 to 1.461, p = 0.365) or cardiovascular (OR 1.100, 95% CI 0.455 to 2.660, p = 0.832) mortality, myocardial infarction (MI; OR 0.362, 95% CI 0.094 to 1.388, p = 0.138), or cerebrovascular accident (CVA; OR 1.200, 95% CI 0.359 to 4.007, p = 0.767) resulting in no difference in the primary study objective of death, MI, or CVA (OR 0.711, 95% CI 0.387 to 1.308, p = 0.273). However, there was an advantage of CABG in major adverse cardiovascular and cerebrovascular events (OR 0.429, 95% CI 0.254 to 0.723, p = 0.001), driven exclusively by target vessel revascularization (OR 0.185, 95% CI 0.079 to 0.432, p |
doi_str_mv | 10.1016/j.amjcard.2014.01.409 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1512224171</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914914005487</els_id><sourcerecordid>3259743661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-46b619e1c8cb5f6be52bcdb4770e25710238db6374b8e1644411934251b2ffc83</originalsourceid><addsrcrecordid>eNqFksuO0zAUhgMC0TLwCCBLbDqLFB_HuW1AQxmGkcpFdGCWVuKczLgkcbGdou54B16AZ-FReBKctty6wQtblr_z-dj6g-AB0ClQSB4vp0W7lIWppowCn1KYcprfDMaQpXkIOUS3gjGllIU58HwU3LV26bcAcXInGDEeZ5AzPr4xmul2VRhldUd0Td6ikb0rOtS9JTNtdFeYDTnvHJo1dk55anKp3DV5bvqr8LTpnequyML5M3tMPqCxf9edGF-3Ic82q8JacmaKeourjlzqFv08mBa4RoPkdWGM_jwc-zbcNZI51o68Kjx86JvURrdbZqv58eXrP93YoRtSazMoLkg7KOSBolIWC4vfv73DK2Wd2RzfC27XRWPx_n49Ct6_OL2YvQznb87OZyfzUHKeuZAnZQI5gsxkGddJiTErZVXyNKXI4hQoi7KqTKKUlxlCwjkHyCPOYihZXcssOgomO-_K6E89WidaZSU2ze7TBcTAGOOQgkcfHaBL3ZvOdzdQfuRplHgq3lHSaGsN1mJlVOvfKoCKISpiKfZREUNUBAXho-LrHu7tfdli9bvqVzY88HQHoP-OtUIjrFTYSayUQelEpdV_r3hyYJCN6pQsmo-4QfvnNcIyQcViyOsQV-CUxjxLo5_QI-xV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1511119736</pqid></control><display><type>article</type><title>Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Buchanan, Gill Louise, MBChB ; Chieffo, Alaide, MD ; Meliga, Emanuele, MD ; Mehran, Roxana, MD ; Park, Seung-Jung, MD ; Onuma, Yoshinobu, MD ; Capranzano, Piera, MD ; Valgimigli, Marco, MD ; Narbute, Inga, MD ; Makkar, Raj R., MD ; Palacios, Igor F., MD ; Kim, Young-Hak, MD ; Buszman, Piotr P., MD ; Chakravarty, Tarun, MD ; Sheiban, Imad, MD ; Naber, Christoph, MD ; Margey, Ronan, MD ; Agnihotri, Arvind, MD ; Marra, Sebastiano, MD ; Capodanno, Davide, MD, PhD ; Allgar, Victoria, BSc (Hons), PhD ; Leon, Martin B., MD ; Moses, Jeffrey W., MD ; Fajadet, Jean, MD ; Lefevre, Thierry, MD ; Morice, Marie-Claude, MD ; Erglis, Andrejs, MD ; Tamburino, Corrado, MD, PhD ; Alfieri, Ottavio, MD ; Serruys, Patrick W., MD ; Colombo, Antonio, MD</creator><creatorcontrib>Buchanan, Gill Louise, MBChB ; Chieffo, Alaide, MD ; Meliga, Emanuele, MD ; Mehran, Roxana, MD ; Park, Seung-Jung, MD ; Onuma, Yoshinobu, MD ; Capranzano, Piera, MD ; Valgimigli, Marco, MD ; Narbute, Inga, MD ; Makkar, Raj R., MD ; Palacios, Igor F., MD ; Kim, Young-Hak, MD ; Buszman, Piotr P., MD ; Chakravarty, Tarun, MD ; Sheiban, Imad, MD ; Naber, Christoph, MD ; Margey, Ronan, MD ; Agnihotri, Arvind, MD ; Marra, Sebastiano, MD ; Capodanno, Davide, MD, PhD ; Allgar, Victoria, BSc (Hons), PhD ; Leon, Martin B., MD ; Moses, Jeffrey W., MD ; Fajadet, Jean, MD ; Lefevre, Thierry, MD ; Morice, Marie-Claude, MD ; Erglis, Andrejs, MD ; Tamburino, Corrado, MD, PhD ; Alfieri, Ottavio, MD ; Serruys, Patrick W., MD ; Colombo, Antonio, MD</creatorcontrib><description>Women typically present with coronary artery disease later than men with more unfavorable clinical and anatomic characteristics. It is unknown whether differences exist in women undergoing treatment for unprotected left main coronary artery (ULMCA) disease. Our aim was to evaluate long-term clinical outcomes in women treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary artery bypass grafting (CABG). All consecutive women from the Drug-Eluting stent for LefT main coronary Artery disease registry with ULMCA disease were analyzed. A propensity matching was performed to adjust for baseline differences. In total, 817 women were included: 489 (59.8%) underwent treatment with PCI with drug-eluting stents versus 328 (40.2%) with CABG. Propensity score matching identified 175 matched pairs, and at long-term follow-up there were no differences in all-cause (odds ratio [OR] 0.722, 95% confidence interval [CI] 0.357 to 1.461, p = 0.365) or cardiovascular (OR 1.100, 95% CI 0.455 to 2.660, p = 0.832) mortality, myocardial infarction (MI; OR 0.362, 95% CI 0.094 to 1.388, p = 0.138), or cerebrovascular accident (CVA; OR 1.200, 95% CI 0.359 to 4.007, p = 0.767) resulting in no difference in the primary study objective of death, MI, or CVA (OR 0.711, 95% CI 0.387 to 1.308, p = 0.273). However, there was an advantage of CABG in major adverse cardiovascular and cerebrovascular events (OR 0.429, 95% CI 0.254 to 0.723, p = 0.001), driven exclusively by target vessel revascularization (OR 0.185, 95% CI 0.079 to 0.432, p <0.001). In women with significant ULMCA disease, no difference was observed after PCI or CABG in death, MI, and CVA at long-term follow-up.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2014.01.409</identifier><identifier>PMID: 24581924</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Angina pectoris ; Cardiology ; Cardiovascular ; Coronary Angiography ; Coronary Artery Bypass - methods ; Coronary Stenosis - diagnostic imaging ; Coronary Stenosis - surgery ; Coronary vessels ; Coronary Vessels - surgery ; Drug-Eluting Stents ; Female ; Follow-Up Studies ; Heart attacks ; Humans ; Mortality ; Percutaneous Coronary Intervention - methods ; Propensity Score ; Registries ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Stents ; Time Factors ; Treatment Outcome</subject><ispartof>The American journal of cardiology, 2014-04, Vol.113 (8), p.1348-1355</ispartof><rights>Elsevier Inc.</rights><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 15, 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-46b619e1c8cb5f6be52bcdb4770e25710238db6374b8e1644411934251b2ffc83</citedby><cites>FETCH-LOGICAL-c448t-46b619e1c8cb5f6be52bcdb4770e25710238db6374b8e1644411934251b2ffc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1511119736?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24581924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchanan, Gill Louise, MBChB</creatorcontrib><creatorcontrib>Chieffo, Alaide, MD</creatorcontrib><creatorcontrib>Meliga, Emanuele, MD</creatorcontrib><creatorcontrib>Mehran, Roxana, MD</creatorcontrib><creatorcontrib>Park, Seung-Jung, MD</creatorcontrib><creatorcontrib>Onuma, Yoshinobu, MD</creatorcontrib><creatorcontrib>Capranzano, Piera, MD</creatorcontrib><creatorcontrib>Valgimigli, Marco, MD</creatorcontrib><creatorcontrib>Narbute, Inga, MD</creatorcontrib><creatorcontrib>Makkar, Raj R., MD</creatorcontrib><creatorcontrib>Palacios, Igor F., MD</creatorcontrib><creatorcontrib>Kim, Young-Hak, MD</creatorcontrib><creatorcontrib>Buszman, Piotr P., MD</creatorcontrib><creatorcontrib>Chakravarty, Tarun, MD</creatorcontrib><creatorcontrib>Sheiban, Imad, MD</creatorcontrib><creatorcontrib>Naber, Christoph, MD</creatorcontrib><creatorcontrib>Margey, Ronan, MD</creatorcontrib><creatorcontrib>Agnihotri, Arvind, MD</creatorcontrib><creatorcontrib>Marra, Sebastiano, MD</creatorcontrib><creatorcontrib>Capodanno, Davide, MD, PhD</creatorcontrib><creatorcontrib>Allgar, Victoria, BSc (Hons), PhD</creatorcontrib><creatorcontrib>Leon, Martin B., MD</creatorcontrib><creatorcontrib>Moses, Jeffrey W., MD</creatorcontrib><creatorcontrib>Fajadet, Jean, MD</creatorcontrib><creatorcontrib>Lefevre, Thierry, MD</creatorcontrib><creatorcontrib>Morice, Marie-Claude, MD</creatorcontrib><creatorcontrib>Erglis, Andrejs, MD</creatorcontrib><creatorcontrib>Tamburino, Corrado, MD, PhD</creatorcontrib><creatorcontrib>Alfieri, Ottavio, MD</creatorcontrib><creatorcontrib>Serruys, Patrick W., MD</creatorcontrib><creatorcontrib>Colombo, Antonio, MD</creatorcontrib><title>Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry)</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Women typically present with coronary artery disease later than men with more unfavorable clinical and anatomic characteristics. It is unknown whether differences exist in women undergoing treatment for unprotected left main coronary artery (ULMCA) disease. Our aim was to evaluate long-term clinical outcomes in women treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary artery bypass grafting (CABG). All consecutive women from the Drug-Eluting stent for LefT main coronary Artery disease registry with ULMCA disease were analyzed. A propensity matching was performed to adjust for baseline differences. In total, 817 women were included: 489 (59.8%) underwent treatment with PCI with drug-eluting stents versus 328 (40.2%) with CABG. Propensity score matching identified 175 matched pairs, and at long-term follow-up there were no differences in all-cause (odds ratio [OR] 0.722, 95% confidence interval [CI] 0.357 to 1.461, p = 0.365) or cardiovascular (OR 1.100, 95% CI 0.455 to 2.660, p = 0.832) mortality, myocardial infarction (MI; OR 0.362, 95% CI 0.094 to 1.388, p = 0.138), or cerebrovascular accident (CVA; OR 1.200, 95% CI 0.359 to 4.007, p = 0.767) resulting in no difference in the primary study objective of death, MI, or CVA (OR 0.711, 95% CI 0.387 to 1.308, p = 0.273). However, there was an advantage of CABG in major adverse cardiovascular and cerebrovascular events (OR 0.429, 95% CI 0.254 to 0.723, p = 0.001), driven exclusively by target vessel revascularization (OR 0.185, 95% CI 0.079 to 0.432, p <0.001). In women with significant ULMCA disease, no difference was observed after PCI or CABG in death, MI, and CVA at long-term follow-up.</description><subject>Aged</subject><subject>Angina pectoris</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Coronary Angiography</subject><subject>Coronary Artery Bypass - methods</subject><subject>Coronary Stenosis - diagnostic imaging</subject><subject>Coronary Stenosis - surgery</subject><subject>Coronary vessels</subject><subject>Coronary Vessels - surgery</subject><subject>Drug-Eluting Stents</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Mortality</subject><subject>Percutaneous Coronary Intervention - methods</subject><subject>Propensity Score</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Stents</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFksuO0zAUhgMC0TLwCCBLbDqLFB_HuW1AQxmGkcpFdGCWVuKczLgkcbGdou54B16AZ-FReBKctty6wQtblr_z-dj6g-AB0ClQSB4vp0W7lIWppowCn1KYcprfDMaQpXkIOUS3gjGllIU58HwU3LV26bcAcXInGDEeZ5AzPr4xmul2VRhldUd0Td6ikb0rOtS9JTNtdFeYDTnvHJo1dk55anKp3DV5bvqr8LTpnequyML5M3tMPqCxf9edGF-3Ic82q8JacmaKeourjlzqFv08mBa4RoPkdWGM_jwc-zbcNZI51o68Kjx86JvURrdbZqv58eXrP93YoRtSazMoLkg7KOSBolIWC4vfv73DK2Wd2RzfC27XRWPx_n49Ct6_OL2YvQznb87OZyfzUHKeuZAnZQI5gsxkGddJiTErZVXyNKXI4hQoi7KqTKKUlxlCwjkHyCPOYihZXcssOgomO-_K6E89WidaZSU2ze7TBcTAGOOQgkcfHaBL3ZvOdzdQfuRplHgq3lHSaGsN1mJlVOvfKoCKISpiKfZREUNUBAXho-LrHu7tfdli9bvqVzY88HQHoP-OtUIjrFTYSayUQelEpdV_r3hyYJCN6pQsmo-4QfvnNcIyQcViyOsQV-CUxjxLo5_QI-xV</recordid><startdate>20140415</startdate><enddate>20140415</enddate><creator>Buchanan, Gill Louise, MBChB</creator><creator>Chieffo, Alaide, MD</creator><creator>Meliga, Emanuele, MD</creator><creator>Mehran, Roxana, MD</creator><creator>Park, Seung-Jung, MD</creator><creator>Onuma, Yoshinobu, MD</creator><creator>Capranzano, Piera, MD</creator><creator>Valgimigli, Marco, MD</creator><creator>Narbute, Inga, MD</creator><creator>Makkar, Raj R., MD</creator><creator>Palacios, Igor F., MD</creator><creator>Kim, Young-Hak, MD</creator><creator>Buszman, Piotr P., MD</creator><creator>Chakravarty, Tarun, MD</creator><creator>Sheiban, Imad, MD</creator><creator>Naber, Christoph, MD</creator><creator>Margey, Ronan, MD</creator><creator>Agnihotri, Arvind, MD</creator><creator>Marra, Sebastiano, MD</creator><creator>Capodanno, Davide, MD, PhD</creator><creator>Allgar, Victoria, BSc (Hons), PhD</creator><creator>Leon, Martin B., MD</creator><creator>Moses, Jeffrey W., MD</creator><creator>Fajadet, Jean, MD</creator><creator>Lefevre, Thierry, MD</creator><creator>Morice, Marie-Claude, MD</creator><creator>Erglis, Andrejs, MD</creator><creator>Tamburino, Corrado, MD, PhD</creator><creator>Alfieri, Ottavio, MD</creator><creator>Serruys, Patrick W., MD</creator><creator>Colombo, Antonio, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20140415</creationdate><title>Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry)</title><author>Buchanan, Gill Louise, MBChB ; Chieffo, Alaide, MD ; Meliga, Emanuele, MD ; Mehran, Roxana, MD ; Park, Seung-Jung, MD ; Onuma, Yoshinobu, MD ; Capranzano, Piera, MD ; Valgimigli, Marco, MD ; Narbute, Inga, MD ; Makkar, Raj R., MD ; Palacios, Igor F., MD ; Kim, Young-Hak, MD ; Buszman, Piotr P., MD ; Chakravarty, Tarun, MD ; Sheiban, Imad, MD ; Naber, Christoph, MD ; Margey, Ronan, MD ; Agnihotri, Arvind, MD ; Marra, Sebastiano, MD ; Capodanno, Davide, MD, PhD ; Allgar, Victoria, BSc (Hons), PhD ; Leon, Martin B., MD ; Moses, Jeffrey W., MD ; Fajadet, Jean, MD ; Lefevre, Thierry, MD ; Morice, Marie-Claude, MD ; Erglis, Andrejs, MD ; Tamburino, Corrado, MD, PhD ; Alfieri, Ottavio, MD ; Serruys, Patrick W., MD ; Colombo, Antonio, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-46b619e1c8cb5f6be52bcdb4770e25710238db6374b8e1644411934251b2ffc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Angina pectoris</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Coronary Angiography</topic><topic>Coronary Artery Bypass - methods</topic><topic>Coronary Stenosis - diagnostic imaging</topic><topic>Coronary Stenosis - surgery</topic><topic>Coronary vessels</topic><topic>Coronary Vessels - surgery</topic><topic>Drug-Eluting Stents</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Mortality</topic><topic>Percutaneous Coronary Intervention - methods</topic><topic>Propensity Score</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Stents</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchanan, Gill Louise, MBChB</creatorcontrib><creatorcontrib>Chieffo, Alaide, MD</creatorcontrib><creatorcontrib>Meliga, Emanuele, MD</creatorcontrib><creatorcontrib>Mehran, Roxana, MD</creatorcontrib><creatorcontrib>Park, Seung-Jung, MD</creatorcontrib><creatorcontrib>Onuma, Yoshinobu, MD</creatorcontrib><creatorcontrib>Capranzano, Piera, MD</creatorcontrib><creatorcontrib>Valgimigli, Marco, MD</creatorcontrib><creatorcontrib>Narbute, Inga, MD</creatorcontrib><creatorcontrib>Makkar, Raj R., MD</creatorcontrib><creatorcontrib>Palacios, Igor F., MD</creatorcontrib><creatorcontrib>Kim, Young-Hak, MD</creatorcontrib><creatorcontrib>Buszman, Piotr P., MD</creatorcontrib><creatorcontrib>Chakravarty, Tarun, MD</creatorcontrib><creatorcontrib>Sheiban, Imad, MD</creatorcontrib><creatorcontrib>Naber, Christoph, MD</creatorcontrib><creatorcontrib>Margey, Ronan, MD</creatorcontrib><creatorcontrib>Agnihotri, Arvind, MD</creatorcontrib><creatorcontrib>Marra, Sebastiano, MD</creatorcontrib><creatorcontrib>Capodanno, Davide, MD, PhD</creatorcontrib><creatorcontrib>Allgar, Victoria, BSc (Hons), PhD</creatorcontrib><creatorcontrib>Leon, Martin B., MD</creatorcontrib><creatorcontrib>Moses, Jeffrey W., MD</creatorcontrib><creatorcontrib>Fajadet, Jean, MD</creatorcontrib><creatorcontrib>Lefevre, Thierry, MD</creatorcontrib><creatorcontrib>Morice, Marie-Claude, MD</creatorcontrib><creatorcontrib>Erglis, Andrejs, MD</creatorcontrib><creatorcontrib>Tamburino, Corrado, MD, PhD</creatorcontrib><creatorcontrib>Alfieri, Ottavio, MD</creatorcontrib><creatorcontrib>Serruys, Patrick W., MD</creatorcontrib><creatorcontrib>Colombo, Antonio, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchanan, Gill Louise, MBChB</au><au>Chieffo, Alaide, MD</au><au>Meliga, Emanuele, MD</au><au>Mehran, Roxana, MD</au><au>Park, Seung-Jung, MD</au><au>Onuma, Yoshinobu, MD</au><au>Capranzano, Piera, MD</au><au>Valgimigli, Marco, MD</au><au>Narbute, Inga, MD</au><au>Makkar, Raj R., MD</au><au>Palacios, Igor F., MD</au><au>Kim, Young-Hak, MD</au><au>Buszman, Piotr P., MD</au><au>Chakravarty, Tarun, MD</au><au>Sheiban, Imad, MD</au><au>Naber, Christoph, MD</au><au>Margey, Ronan, MD</au><au>Agnihotri, Arvind, MD</au><au>Marra, Sebastiano, MD</au><au>Capodanno, Davide, MD, PhD</au><au>Allgar, Victoria, BSc (Hons), PhD</au><au>Leon, Martin B., MD</au><au>Moses, Jeffrey W., MD</au><au>Fajadet, Jean, MD</au><au>Lefevre, Thierry, MD</au><au>Morice, Marie-Claude, MD</au><au>Erglis, Andrejs, MD</au><au>Tamburino, Corrado, MD, PhD</au><au>Alfieri, Ottavio, MD</au><au>Serruys, Patrick W., MD</au><au>Colombo, Antonio, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry)</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2014-04-15</date><risdate>2014</risdate><volume>113</volume><issue>8</issue><spage>1348</spage><epage>1355</epage><pages>1348-1355</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Women typically present with coronary artery disease later than men with more unfavorable clinical and anatomic characteristics. It is unknown whether differences exist in women undergoing treatment for unprotected left main coronary artery (ULMCA) disease. Our aim was to evaluate long-term clinical outcomes in women treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary artery bypass grafting (CABG). All consecutive women from the Drug-Eluting stent for LefT main coronary Artery disease registry with ULMCA disease were analyzed. A propensity matching was performed to adjust for baseline differences. In total, 817 women were included: 489 (59.8%) underwent treatment with PCI with drug-eluting stents versus 328 (40.2%) with CABG. Propensity score matching identified 175 matched pairs, and at long-term follow-up there were no differences in all-cause (odds ratio [OR] 0.722, 95% confidence interval [CI] 0.357 to 1.461, p = 0.365) or cardiovascular (OR 1.100, 95% CI 0.455 to 2.660, p = 0.832) mortality, myocardial infarction (MI; OR 0.362, 95% CI 0.094 to 1.388, p = 0.138), or cerebrovascular accident (CVA; OR 1.200, 95% CI 0.359 to 4.007, p = 0.767) resulting in no difference in the primary study objective of death, MI, or CVA (OR 0.711, 95% CI 0.387 to 1.308, p = 0.273). However, there was an advantage of CABG in major adverse cardiovascular and cerebrovascular events (OR 0.429, 95% CI 0.254 to 0.723, p = 0.001), driven exclusively by target vessel revascularization (OR 0.185, 95% CI 0.079 to 0.432, p <0.001). In women with significant ULMCA disease, no difference was observed after PCI or CABG in death, MI, and CVA at long-term follow-up.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24581924</pmid><doi>10.1016/j.amjcard.2014.01.409</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2014-04, Vol.113 (8), p.1348-1355 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_miscellaneous_1512224171 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
subjects | Aged Angina pectoris Cardiology Cardiovascular Coronary Angiography Coronary Artery Bypass - methods Coronary Stenosis - diagnostic imaging Coronary Stenosis - surgery Coronary vessels Coronary Vessels - surgery Drug-Eluting Stents Female Follow-Up Studies Heart attacks Humans Mortality Percutaneous Coronary Intervention - methods Propensity Score Registries Retrospective Studies Risk Factors Severity of Illness Index Stents Time Factors Treatment Outcome |
title | Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Percutaneous%20Coronary%20Intervention%20(With%20Drug-Eluting%20Stents)%20Versus%20Coronary%20Artery%20Bypass%20Grafting%20in%20Women%20With%20Severe%20Narrowing%20of%20the%20Left%20Main%20Coronary%20Artery%20(from%20the%20Women%E2%80%93Drug-Eluting%20stent%20for%20LefT%20main%20coronary%20Artery%20disease%C2%A0Registry)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Buchanan,%20Gill%20Louise,%20MBChB&rft.date=2014-04-15&rft.volume=113&rft.issue=8&rft.spage=1348&rft.epage=1355&rft.pages=1348-1355&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2014.01.409&rft_dat=%3Cproquest_cross%3E3259743661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1511119736&rft_id=info:pmid/24581924&rft_els_id=S0002914914005487&rfr_iscdi=true |